OssDsign

OssDsign Interest Coverage

The Interest Coverage Ratio of OssDsign (OSSD.ST) as of Nov 3, 2026 is -14.17. In the previous year, Interest Coverage Ratio was -144.10 — a change of -90.17% (higher).

Interest Coverage

-14.17

YoY

-90.17%

Last updated:

Interest Coverage Ratio of OssDsign is 2025 -14.17 . Interest Coverage Ratio of OssDsign was 2024 -144.10 . It decreases by -90.17% higher compared to the previous year.

The OssDsign Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
-8.77 SEK
Jan 1, 2019
-369.58 SEK
Jan 1, 2020
-138.05 SEK
Jan 1, 2021
-20.26 SEK
Jan 1, 2022
-33.29 SEK
Jan 1, 2023
-32.95 SEK
Jan 1, 2024
-144.10 SEK
Jan 1, 2025
-14.17 SEK
The OssDsign Interest Coverage history
YEARInterest CoverageYoY
-14.17-90.17%
-144.10+337.36%
-32.95-1.04%
-33.29+64.32%
-20.26-85.32%
-138.05-62.65%
-369.58+4,112.87%
-8.77-34.16%
-13.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OssDsign Stock analysis

What does OssDsign do? OssDsign AB develops and sells medical technology products, focusing on implantable solutions for bone healing, particularly in skull surgery. Its primary product, Craniomosaic, is an implant for skull defect repair (cranioplasty), while it also develops bioceramic implants for facial bone augmentation. The company uses proprietary bioceramic technologies that integrate with tissues and support bone ingrowth. Customers include neurosurgeons, craniofacial, and maxillofacial surgeons who purchase these products for surgical procedures. The company generates revenue through the development and sales of its medical technology products, specifically Craniomosaic and bioceramic implants for facial bone augmentation. These products are sold to surgeons specializing in skull and facial bone procedures. The firm’s focus on proprietary bioceramic technologies differentiates its offerings in the medical device market, targeting healthcare professionals who require advanced solutions for bone healing challenges. OssDsign AB’s business model centers on selling implantable medical devices developed using its unique bioceramic technologies. The company’s main customers are neurosurgeons, craniofacial surgeons, and maxillofacial surgeons who use Craniomosaic and facial bone augmentation implants during surgical operations. Revenue is derived from the direct sale of these products to medical professionals for clinical applications in bone healing and reconstruction. OssDsign is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OssDsign stock

Interest Coverage Ratio of OssDsign is -14.17 in 2025.

Interest Coverage Ratio of OssDsign changed from -144.10 to -14.17, representing a -90.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio OssDsign since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's OssDsign with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — OssDsign

All Key Metrics — OssDsign